30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Jack Callicutt

Track

Insider profile

Currently holds a position at Galectin Therapeutics Inc

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Secretary Galectin Therapeutics Inc July 8, 2018 -
Chief Financial Officer Galectin Therapeutics Inc July 1, 2013 - July 8, 2018
Jack Callicutt's trades of Galectin Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-06 2026-01-06
PlS Planned sale
32,994 -17.9%
56.35
US$4,825,189 		32,994 -17.9% 56.35 US$4,825,189
2026-01-06 2026-01-05
PlS Planned sale
95,020 -14.3%
346.78
US$1,458,108 		95,020 -14.3% 346.78 US$1,458,108
2026-01-06 2026-01-02
PlS Planned sale
31,926 -42.1%
208.18
US$107,540 		31,926 -42.1% 208.18 US$107,540
2026-01-05 2026-01-02
PrS Proposed sale
60,000
4.20
US$252,000 		60,000 4.20 US$252,000
2026-01-02 2026-01-02
PrS Proposed sale
141,206
4.20
US$593,065 		141,206 4.20 US$593,065
2025-11-19 2025-11-18
PlS Planned sale
18,210 -70.5%
6.22
US$113,321 		18,210 -70.5% 6.22 US$113,321
2025-11-19 2025-11-18
PlS Planned sale
28,100 -78.7%
6.22
US$174,866 		28,100 -78.7% 6.22 US$174,866
2025-11-19 2025-11-17
PlS Planned sale
2,323 -23.4%
6.03
US$14,012 		2,323 -23.4% 6.03 US$14,012
2025-11-19 2025-11-17
PlS Planned sale
19,701 -72.1%
6.03
US$118,831 		19,701 -72.1% 6.03 US$118,831
2025-11-19 2025-11-17
PlS Planned sale
9,586 -55.7%
6.03
US$57,820 		9,586 -55.7% 6.03 US$57,820
2025-11-12 2025-11-10
PlS Planned sale
1,736 -18.6%
6.03
US$10,468 		1,736 -18.6% 6.03 US$10,468
2025-11-12 2025-11-10
PlS Planned sale
1,675 -18.0%
6.03
US$10,095 		1,675 -18.0% 6.03 US$10,095
2025-11-12 2025-11-10
PlS Planned sale
1,880 -19.8%
6.02
US$11,321 		1,880 -19.8% 6.02 US$11,321
2025-11-07 2025-11-05
PlS Planned sale
200 -2.6%
6.00
US$1,200 		200 -2.6% 6.00 US$1,200
2025-11-07 2025-11-05
PlS Planned sale
200 -2.6%
6.00
US$1,200 		200 -2.6% 6.00 US$1,200
2025-11-07 2025-11-05
PlS Planned sale
200 -2.6%
6.00
US$1,200 		200 -2.6% 6.00 US$1,200
2025-11-05 2025-11-04
PlS Planned sale
10,741 -58.5%
6.07
US$65,198 		10,741 -58.5% 6.07 US$65,198
2025-11-05 2025-11-04
PlS Planned sale
8,974 -54.1%
6.07
US$54,472 		8,974 -54.1% 6.07 US$54,472
2025-11-05 2025-11-04
PlS Planned sale
8,914 -53.9%
6.07
US$54,108 		8,914 -53.9% 6.07 US$54,108
2025-11-05 2025-11-03
PlS Planned sale
1,250 -14.1%
6.01
US$7,512 		1,250 -14.1% 6.01 US$7,512
2025-11-05 2025-11-03
PlS Planned sale
1,260 -14.2%
6.01
US$7,573 		1,260 -14.2% 6.01 US$7,573
2025-11-05 2025-11-03
PlS Planned sale
1,300 -14.6%
6.01
US$7,813 		1,300 -14.6% 6.01 US$7,813
2025-09-15 2025-09-12
PlS Planned sale
8,706 -53.3%
6.44
US$56,054 		8,706 -53.3% 6.44 US$56,054
2025-09-12 2025-09-12
PrS Proposed sale
141,206
6.44
US$909,155 		141,206 6.44 US$909,155
2024-12-26 2024-12-23
PlS Planned sale
40,000 -84.0%
0.89
US$35,492 		40,000 -84.0% 0.89 US$35,492
2024-12-23 2024-12-23
PrS Proposed sale
40,000
1.04
US$41,600 		40,000 1.04 US$41,600
2022-11-17 2022-11-17
B Purchase
4,000 +110.7%
1.32
US$5,280 		4,000 +110.7% 1.32 US$5,280
2019-06-03 2019-05-31
B Purchase
2,354 +186.8%
4.28
US$10,075 		2,354 +186.8% 4.28 US$10,075
2004-05-11 2004-05-07
B Purchase
1,000 +inf%
5.50
US$5,500 		1,000 +inf% 5.50 US$5,500